यह एपिसोड मेक्सिको के नए "एब्रिविएटेड पाथवे" (संक्षिप्त मार्ग) पर केंद्रित है, जो 1 सितंबर, 2025 से प्रभावी होगा। हम बताते हैं कि कैसे मेडिकल डिवाइस निर्माता IMDRF या MDSAP सदस्य बाजारों से मौजूदा प्राधिकरणों का लाभ उठाकर केवल 30 कार्य दिवसों के लक्षित समय में COFEPRIS अनुमोदन प्राप्त कर सकते हैं, जिससे मेक्सिको के बाजार में प्रवेश की प्रक्रिया काफी सुव्यवस्थित हो जाती है। - मेक्सिको ने मेडिकल डिवाइस पंजीकरण के लिए कौन सा नया मार्ग पेश किया है? - यह नया "इक्विवेलेंसी रूट" कब से प्रभावी होगा? -

Questo episodio analizza il nuovo Percorso Abbreviato (Via di Equivalenza) della COFEPRIS in Messico, in vigore dal 1° settembre 2025. Discutiamo di come questa nuova rotta normativa consenta ai produttori di dispositivi medici e IVD di sfruttare le autorizzazioni esistenti dai mercati membri dell'IMDRF e MDSAP per ottenere un'approvazione in Messico con un tempo di revisione target di soli 30 giorni lavorativi, riducendo drasticamente i tempi di immissione sul mercato.- Come possono i produttori

Neste episódio, detalhamos a nova Vía Abreviada (Rota de Equivalência) da COFEPRIS no México, que entrará em vigor em 1 de setembro de 2025. Analisamos como os fabricantes de dispositivos médicos e IVDs podem usar suas aprovações existentes de mercados membros do IMDRF e MDSAP, como EUA, Canadá e União Europeia, para obter uma aprovação regulatória no México em um prazo alvo de apenas 30 dias úteis. Discutimos as implicações estratégicas desta mudança e como ela pode acelerar drasticamente o seu

Cet épisode explore la nouvelle 'Voie Abrégée' (Abbreviated Pathway) pour l'homologation des dispositifs médicaux au Mexique, qui entrera en vigueur le 1er septembre 2025. Nous détaillons comment les fabricants peuvent utiliser leurs autorisations existantes des marchés membres de l'IMDRF ou du MDSAP pour obtenir une approbation de la COFEPRIS en seulement 30 jours ouvrables. Découvrez ce que cette réforme signifie pour votre stratégie d'accès au marché et comment vous préparer à cette opportunité

Laughter is ancient — even rats and chimps do it. It began as a survival signal: “We’re safe now.” Most laughter isn’t from jokes, but from social bonding. Real laughter releases endorphins, boosts immunity, and eases stress. Humor = surprise + safety (the “benign violation” sweet spot). Fake or real, laughter still helps your brain relax and reset. It connects people — syncing heartbeats, breath, and emotion. Sometimes laughter finds us in the hardest moments — and that’s its magic.

Nos acompañan Andrés Sarmiento  y Joel Torices para hablar de turismo deportivo y las ventajas de aprovechar y conservar la naturaleza como lugar de esparcimiento y deporte.

La Dra. Luz Eugenia Alcántara y Md. Fernanda Orduña del CIACYT nos platican la importancia de prevenir y combatir al Cáncer de mama.

In today’s Pharmaceutical Executive Daily, we cover the resignation of Organon CEO Kevin Ali following an internal investigation tied to Nexplanon sales, GSK’s $357 million agreement with Syndivia to expand its antibody-drug conjugate portfolio, and new guidance from the American College of Surgeons classifying obesity as a treatable condition.

In this throwback episode of NGBideas, host Jim Wilson sits down with Brigitte Nolet, President and CEO of Roche Canada Pharma. They explore Brigitte's journey as a trisector leader, her personal experiences as a patient, and her insights into Canada's life sciences sector. Discover the importance of honesty in leadership and the potential of healthcare innovation. Tune in for an inspiring conversation about resilience, ambition, and the future of healthcare in Canada.

Get a look at the latest September/October issue of MEDSURG Nursing! For over 30 years, MEDSURG Nursing has been the trusted resource for advancing evidence-based practice, clinical research, and professional development in medical-surgical nursing.With 3.8 NCPD contact hours available, this issue is packed with opportunities to advance your practice and deliver exceptional care. Visit www.medsurgnursing.net to subscribe or access individual articles. Don’t forget to follow us on social media for

Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.

Denis DubouleChaire Évolution du développement et des génomesCollège de FranceAnnée 2025-2026Nos ancêtres les poissonsConférence - Neil Shubin : The Evolutionary Origins of Bones and TeethNeil ShubinUniversité de Chicago, Président élu de l'Académie nationale des sciences (NAS), États-UnisRésuméTeeth and bones are fundamental features of vertebrate organisms. The earliest vertebrates date from fossils that are over 500 million years old and existed at the time of the Cambrian Explosion, a great

️ Episode 181: Creatine Transporter SLC6A8: Conservation and Variant Impact In this episode of PaperCast Base by Base, we explore how the creatine transporter gene SLC6A8 (CRT1) is evolutionarily conserved across terrestrial mammals and how disease-associated variants alter creatine uptake in vitro, shedding light on genotype–phenotype relationships in creatine transporter deficiency. fileciteturn0file0 Study Highlights:The authors compared CRT1

👉 Para receber diretamente os áudios no seu celular, entre para o grupo: 🔗 https://site.vedanta.com.br/lead/cast-jz Saiba mais sobre esse conhecimento em: https://www.instagram.com/vedanta.soma

Ella Dooly, Ruby Fanning, Giorgi Herterich & Keelan Maloney are all members of T Bay Surf Club in Tramore, Co. Waterford. Thanks to their outstanding performances in competitions this year, they have been selected to join the Irish Team who will travel to Punta Rocas in Peru to represent Ireland at the ISA World Junior Surfing Games. Celebrate this amazing achievement by tuning in to hear their story and, if you are feeling generous and would like to support them on their journey to compete for

In this podcast, Audrey Talley Rostov, MD, and Nandini Venkateswaran, MD, discuss the following topics to help you get started with SMILE:What is SMILE Why they prefer SMILE How to get started with SMILE Common issues when getting started with SMILE: Centration, Identifying Surgical Planes, Difficult Dissections SMILE pre and post operative regimens Where each doctor positions SMILE in their practice

Tom Viola is BACK and he is talking about bath salts... and we are not talking about Dr Teal's epsom salts. Tom shares a little bit of the background of what they are, where they originated, and the difficulties of testing for them. Don't miss this 6 minute episode!

Send us a text In this episode of the Life Science Success Podcast my guest is Troy Fugate. The CCO of Compliance Insight, Inc., Troy brings 30+ years of FDA readiness, GMP, and quality leadership—turning complex requirements into practical, culture-shaping solutions and championing the Align–Apply–Adapt framework used across pharma, cell and gene therapy, and medical devices. 00:00 Introduction to Life Science Success Podcast 00:37 Meet Troy Fugate: CCO of Compliance Insight 01:09 Troy's C...

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Paul McCormack, founder of in10tion Performance, whose journey from alcohol-fuelled routines to

科研喵使用ai读文献，祝你效率百倍，访问labcat.com.cn下载。今天我们要关注发表在《Cancer》(影响因子6.1)上的重要研究《Defining and measuring tolerability in pediatric, adolescent, and young adult oncology: The essential voices》。这项综述提出了儿科肿瘤治疗耐受性的全新定义，强调患者、照顾者和临床医生三种声音的整合对准确评估治疗耐受性的关键作用。研究指出儿科肿瘤临床试验在耐受性评估方面仍有不足，同时介绍了最新进展——将经过验证的测量工具融入临床试验，以记录特定癌症治疗的症状负担。未来研究将聚焦于7岁以下患者耐受性评估方法的建立，并将关注点扩展到生存期耐受性问题，为改善儿科肿瘤治疗体验提供重要指导。